Top Tech Companies (2,068)
Don't see your company?
Create a company profile
VirtualScopics provides imaging solutions for clinical trials in the pharmaceutical, biotechnology, and medical device industries.
Founded by Dr. Benjamin Cravatt, Dr. Jennifer Lippincott-Schwartz, and Dr. Stuart Schreiber.
Lycera engages in the development of small-molecule immunomodulators for the treatment of patients with autoimmune diseases.
Biocept employs cell separation technology to develop a class of diagnostic assays for the early detection and diagnosis of cancer.
Quality Biological (QBI) provides quality solutions for life science research and bioproduction applications. We specialize in producing custom and standard cell culture and molecular biology reagents, buffers, and liquid solutions and providing supporting services. At QBI, we help our clients achieve their application goals faster. We do this by being flexible and nimble, providing a level of personalized service our clients rely on. QBI is home to a fully-equipped, ISO 9001:2015 certified manufacturing facility. At the base of every product is water that exceeds industry specifications. This enables us to provide you with solutions of superior quality and value. We have your solution...whether you need a few liters of medium, buffer or a custom solution for research, dozens of liters of one single lot for process and method validation, or hundreds of liters for commercialization. We work with you to address your specific needs and requirements. Contact us today to discuss your specific media and buffer needs.
WRAL TechWire is a technology-specific news publication that provides news and information about high technologies and the life sciences.
Allucent is on a mission to help bring new therapies to light by solving the distinct challenges of small and mid-sized biotech companies. The company is purpose-built through the convergence of leading providers to address this unmet need. Today, Allucent is a global provider of comprehensive drug development solutions, including consulting, clinical operations, biometrics and clinical pharmacology across a variety of therapeutic areas. With more than 30 years of experience in over 60 countries, Allucent’s individualized partnership approach provides experience-driven insights and expertise to assist its clients in successfully navigating the complexities of delivering novel treatments to patients.
Fzata, Inc. is a pre-clinical stage biopharmaceutical company based in Halethorpe, MD within the vibrant BioHealth Capital Region. Fzata’s vision is to reduce health inequities by expanding patient access to therapeutic biologics. This is made possible with our proprietary first-in-class oral Bioengineered Probiotic Yeast Medicines (BioPYM™) platform. BioPYM enables orally administered yeast micro-factories to make biologic therapeutics “on-site” in the gut for treatment of GI disorders like infectious diseases, inflammation, metabolic diseases, (e.g., diabetes), colon cancer, and more. Our oral biologic drug candidates are intended to help patients that inject biologic medicine by 1) improving patient accessibility to biologics with affordable, non-refrigerated, convenient oral capsules, 2) improving patient compliance with no needles and no need for health-care administration and 3) improving patient outcomes given the expected high safety profile for chronic use.
Intuitive Biosciences provides tuberculosis and specific pathogen-free tests for non-human primate (NHP) research operations.
Since its establishment in 1992, KTI has enjoyed over 25 years of participating in a wide range of biotech/clinical research projects working with many regional and national biotech businesses and governmental agencies. Dedicated to excellence in advancing fields of biotechnology and biomedical research, KamTek has always attracted talent and derived its strength from a highly innovative and professional team with expertise in newly evolving areas of Molecular Biology, Immunology, Microbiology, Cell Biology, Genetics, Virology, and Tumor Biology. KamTek also maintains a perfectly equipped bio-repository designed to manage safety and integrity of bio-specimens, a crucial ingredient of any biomedical/biotech research operation. At KamTek state-of-the-art biotech projects are executed by highly trained and dedicated staff in collaboration with instrumentation experts, information technology professionals and various other service providers working as a cohesive team. KTI operates efficiently with a diligent team, many of whom are cross-trained, and a highly experienced group of close, collaborative Associates. KTI’s ever-evolving, state-of-the-art services have allowed it to maintain a sound financial base. The company has also attracted angel investments to supplement government funding and uses internal resources to support its key projects. KTI has also received grants from National Institute of Health under SBIR program.
Breethe is a medical device company that develops a compact artificial lung for patients with acute and chronic lung problems.
Calico is an Alphabet-founded research and development company whose mission is to harness advanced technologies and model systems to increase our understanding of the biology that controls human aging. We will use that knowledge to devise interventions that enable people to lead longer and healthier lives. Calico’s highly innovative technology labs, its commitment to curiosity-driven discovery science and, with academic and industry partners, its vibrant drug-development pipeline together create an inspiring and exciting place to catalyze and enable medical breakthroughs. Calico is currently seeking exceptional candidates who share our passion for understanding the science of aging and developing therapeutics to address age-related diseases. Explore with us! https://www.calicolabs.com/careers
Athersys is a clinical stage biopharmaceutical company with a growing pipeline of highly differentiated, potential best in class therapeutics to treat significant and life-threatening diseases. We are engaged in the discovery and development of innovative new medicines designed to extend and enhance the quality of human life. Through the application of our proprietary technologies, we have established a pipeline of therapeutic product development programs in multiple disease areas. This pipeline includes both stem cell therapy and pharmaceuticals.
Aziyo Biologics is a fully integrated, commercially oriented regenerative medicine company. Since its founding in 2015 the Company has expanded through acquisitions and strategic partnerships, creating a high growth commercial entity. Its proprietary products are used in orthopedic, cardiovascular and other medical specialties.
AUM BioTech offers self-delivering Gene silencing products for basic and pre-clinical research.
Ansun BioPharma is a clinical-stage biopharmaceutical company focused on the development of host-directed anti-viral.
APT Therapeutics is a Biotechnology company located in 4041 Forest Park Ave., St. Louis, MO, United States.
BioMap is an AI for life sciences company, unmasking nature’s rules to generate proteins for a wide range of therapeutic and industrial applications. We build super-scale Foundation models supported by access to unrivaled computational power through our strategic collaboration with Baidu, with whom we share our Founder and Chairman, Robin Li. We supplement our AI capabilities with a leading team of scientists, disease experts and cutting-edge high-throughput labs which generate large volumes of high quality proprietary data for our AI models. We partner with pharma, biotechs and industry to enable their discovery ambitions across a wide range of therapeutic and synthetic biology modalities through access to our AI technology platform, with a variety of flexible collaboration models. Our mission is to leverage AI to radically improve lives
Spectrum CannaLabs is an analytical testing laboratory that provides testing solutions for legal cannabis products.
IconOVir Bio is a preclinical-stage biotechnology company pioneering the next generation of oncolytic virus therapy to improve the treatment of patients with cancer. Our proprietary oncolytic virus platform is based on technology developed by scientific founder Clodagh O’Shea, Ph.D., of the Salk Institute. It is designed to address key limitations of first- and second-generation oncolytic viruses.
